Biomerieux, Inc.

Centre National De La Recherche Scientifique

Institut Curie

Yasemin Ataman-Önal

Jean-Philippe Charrier

Sandrine Busseret

Corinne Beaulieu

Dominique Rolland

Monique Arpin

Sylvie Pons

Geneviève Choquet-Kastylevsky

Florence Poirier

Sandrine Michel-busseret

Gaspard Gervasi

Emanuelle Gallet-Gorius

Michèle Guillotte

Céline Hamelin

The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumor marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer.

Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer

The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumour marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer.

Growing community of inventors

Reyrieux, France

Yasemin Ataman-Önal